Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Waystar Holding Corp. ( (WAY) ) is now available.
On October 1, 2025, Waystar Holding Corp. completed its acquisition of Iodine Software, enhancing its AI-powered healthcare payment platform by integrating Iodine’s clinical and financial intelligence. This acquisition expands Waystar’s market by over 15% and is expected to improve its financial profile through increased gross margin and revenue growth. The merger, valued at approximately $458.6 million in cash and stock, also led to the appointment of Lauren Young to Waystar’s board, reflecting the strategic importance of the acquisition in strengthening Waystar’s position in the healthcare industry.
The most recent analyst rating on (WAY) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on Waystar Holding Corp. stock, see the WAY Stock Forecast page.
Spark’s Take on WAY Stock
According to Spark, TipRanks’ AI Analyst, WAY is a Outperform.
Waystar Holding Corp. receives a strong overall score driven by robust financial performance and a positive earnings call. The company’s strategic initiatives and AI-driven innovations position it well for future growth. However, the high P/E ratio and lack of dividend yield weigh down the valuation score.
To see Spark’s full report on WAY stock, click here.
More about Waystar Holding Corp.
Waystar Holding Corp. is a provider of healthcare payment software, serving approximately 30,000 clients and processing over 6 billion healthcare payment transactions annually. The company’s platform is designed to simplify healthcare payments, allowing providers to focus on patient care and optimize financial performance. Waystar’s clients include 16 of the top 20 institutions on the U.S. News Best Hospitals list, and its platform handles over $1.8 trillion in annual gross claims, covering about 50% of U.S. patients.
Average Trading Volume: 2,480,527
Technical Sentiment Signal: Hold
Current Market Cap: $6.53B
See more data about WAY stock on TipRanks’ Stock Analysis page.